Fetal liver macrophages contribute to the hematopoietic stem cell niche by controlling granulopoiesis.

developmental biology immunology inflammation mouse

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
25 Mar 2024
Historique:
received: 29 01 2023
accepted: 23 03 2024
medline: 25 3 2024
pubmed: 25 3 2024
entrez: 25 3 2024
Statut: aheadofprint

Résumé

During embryogenesis, the fetal liver becomes the main hematopoietic organ, where stem and progenitor cells as well as immature and mature immune cells form an intricate cellular network. Hematopoietic stem cells (HSCs) reside in a specialized niche, which is essential for their proliferation and differentiation. However, the cellular and molecular determinants contributing to this fetal HSC niche remain largely unknown. Macrophages are the first differentiated hematopoietic cells found in the developing liver, where they are important for fetal erythropoiesis by promoting erythrocyte maturation and phagocytosing expelled nuclei. Yet, whether macrophages play a role in fetal hematopoiesis beyond serving as a niche for maturing erythroblasts remains elusive. Here, we investigate the heterogeneity of macrophage populations in the murine fetal liver to define their specific roles during hematopoiesis. Using a single-cell omics approach combined with spatial proteomics and genetic fate-mapping models, we found that fetal liver macrophages cluster into distinct yolk sac-derived subpopulations and that long-term HSCs are interacting preferentially with one of the macrophage subpopulations. Fetal livers lacking macrophages show a delay in erythropoiesis and have an increased number of granulocytes, which can be attributed to transcriptional reprogramming and altered differentiation potential of long-term HSCs. Together, our data provide a detailed map of fetal liver macrophage subpopulations and implicate macrophages as part of the fetal HSC niche.

Identifiants

pubmed: 38526524
doi: 10.7554/eLife.86493
pii: 86493
doi:
pii:

Banques de données

Dryad
['10.5061/dryad.fn2z34v00']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : EXC2151-390873048
Organisme : Deutsche Forschungsgemeinschaft
ID : 505539112
Organisme : Horizon 2020 Framework Programme
ID : 101039438
Organisme : Deutsche Forschungsgemeinschaft
ID : GRK2168
Organisme : Deutsche Forschungsgemeinschaft
ID : GRK1873/2
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB1454
Organisme : Deutsche Forschungsgemeinschaft
ID : FOR5547 - Project-ID 503306912
Organisme : Horizon 2020 Framework Programme
ID : 851257
Organisme : Deutsche Forschungsgemeinschaft
ID : 448121430
Organisme : Deutsche Forschungsgemeinschaft
ID : 405969122

Informations de copyright

© 2024, Kayvanjoo et al.

Déclaration de conflit d'intérêts

AK, IS, DB, HH, KM, NM, DH, HT, NB, EG, CO, KB, JS, SU, EK, MB, AS, EM The authors declare that no competing interests exist.

Auteurs

Amir Hossein Kayvanjoo (AH)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Iva Splichalova (I)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

David Alejandro Bejarano (DA)

Quantitative Systems Biology, University of Bonn, Bonn, Germany.

Hao Huang (H)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Katharina Mauel (K)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Nikola Makdissi (N)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

David Heider (D)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Hui Ming Tew (HM)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Nora Reka Balzer (NR)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Eric Greto (E)

Department of Internal Medicine 3-Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.

Collins Osei-Sarpong (C)

Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases, Bonn, Germany.

Kevin Baßler (K)

Genomics and Immunoregulation, University of Bonn, Bonn, Germany.

Joachim L Schultze (JL)

Genomics and Immunoregulation, University of Bonn, Bonn, Germany.

Stefan Uderhardt (S)

Department of Internal Medicine 3-Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany.

Eva Kiermaier (E)

Immune and Tumor Biology, University of Bonn, Bonn, Germany.

Marc Beyer (M)

Genomics and Immunoregulation, University of Bonn, Bonn, Germany.

Andreas Schlitzer (A)

Quantitative Systems Biology, University of Bonn, Bonn, Germany.

Elvira Mass (E)

Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.

Classifications MeSH